Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-20

FDA Approved: CITALOPRAM HYDROBROMIDE — Supplemental Application (Glenmark Therapeutics Inc., USA)

View source ↗

Summary

FDA approved Glenmark Therapeutics’ supplemental application for Citalopram Hydrobromide as a generic antidepressant. Citalopram hydrobromide is used to treat m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram Hydrobromide (citalopram hydrobromide)

Snippet

SUPPL AP for CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE)